drugset / Trial / NCT02086929
Trazodone Once a Day in Major Depression Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
The study objective is to evaluate the efficacy and safety of trazodone OAD vs venlafaxine extended release (venlafaxine XR) after an 8-week treatment period in patients with major depressive disorder.
Timeline
- Start
- 2012-12
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trazodone | Small molecule | 300 mg | — |
| Comparator | Venlafaxine | Small molecule | 75 mg | — |